| Financial Year |
March 31 2023 |
| Monetary Funds |
1,154,618,796.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,615,869.69 |
| Accounts Receivable |
1,174,668,733.30 |
| Advances to Suppliers |
183,016,592.75 |
| Other Receivables |
8,068,005.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
329,728,055.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,472,892.77 |
| Other Current Assets |
6,428,019.26 |
| Total Current Assets |
2,867,616,966.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,454,137.39 |
| Long-term Equity Investment |
503,997,516.46 |
| Investment Properties |
6,063,464.08 |
| Fixed Assetes |
559,798,529.75 |
| Under-construction Projects |
88,539,480.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,158,296.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
230,987.27 |
| Deferred Income Tax Assets |
161,650,657.43 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,528,248,798.23 |
| Total Assets |
4,395,865,764.31 |
| Short-Term Loans |
520,458,546.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,650,000.00 |
| Accounts Payable |
1,416,028,393.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
133,370,439.44 |
| Taxes Payable |
38,041,646.47 |
| Interest Payable |
-- |
| Dividend Payable |
4,357,459.11 |
| Other payables |
502,770,087.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,550,144.41 |
| Other Current Liabilities |
464,968.08 |
| Sub-Total of Current Liabilities |
2,668,825,160.70 |
| Long-term Loans |
185,823,333.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
76,265,712.57 |
| Deferred Income Tax Liabilities |
16,858,792.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
347,458,680.40 |
| Total Liabilities |
3,016,283,841.10 |
| Paid-In Capital(Or Share Stock) |
1,311,200,558.00 |
| Capital Surplus |
1,617,074,818.94 |
| Surplus Reserve |
413,706,454.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,343,985,774.11 |
| Minority Stockholder's Interest |
389,744,764.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
989,837,158.33 |
| Owner's Equity（Stockholder's Equity） |
1,379,581,923.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,395,865,764.31 |
